Abstract
Pre-eclampsia is a principal cause of maternal morbidity and mortality, affecting 5–10% of first pregnancies worldwide. Manifestations include increased blood pressure, proteinuria, coagulopathy and peripheral and cerebral oedema. Although the aetiology and pathogenesis remain to be elucidated, the placenta is undoubtedly involved, as termination of pregnancy eradicates the disease. Here we have cloned a complementary DNA from human placental messenger RNA encoding a precursor protein of 121 amino acids which gives rise to a mature peptide identical to the neuropeptide neurokinin B (NKB)1 of other mammalian species. In female rats, concentrations of NKB several-fold above that of an animal 20 days into pregnancy caused substantial pressor activity. In human pregnancy, the expression of NKB was confined to the outer syncytiotrophoblast of the placenta, significant concentrations of NKB could be detected in plasma as early as week 9, and plasma concentrations of NKB were grossly elevated in pregnancy-induced hypertension and pre-eclampsia. We conclude that elevated levels of NKB in early pregnancy may be an indicator of hypertension and pre-eclampsia, and that treatment with certain neurokinin receptor antagonists may be useful in alleviating the symptoms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kangawa, K., Minamino, N., Fukuda, A. & Matsuo, H. Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 114, 533– 540 (1983).
von Euler, U. S. & Gaddum, J. H. An unidentified depressor substance in certain tissue extracts. J. Physiol. 72, 74–87 (1931).
Kimura, S., Okada, K., Sugita, Y., Kanazawa, I. & Munekata, E. Novel peptides neuropeptides, neurokinin α and β, isolated from porcine spinal cord. Proc. Japan Acad. B 59, 101–104 (1983).
Longmore, J., Hill, R. G. & Hargreaves, R. J. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs. Canadian J. Physio. & Pharmacol. 75, 612–621 ( 1997).
Mastrangelo, D. et al. The rat isolated portal vein: a preparation sensitive to neurokinins, particularly neurokinin B. Eur. J. Pharmacol. 134, 321–326 (1987).
D'Orleans-Juste, P., Claing, A., Telemaque, S., Warner, T. D. & Regoli, D. Neurokinins produce selective venoconstriction via NK-3 receptors in the rat mesenteric vascular bed. Eur. J. Pharmacol. 204, 329–334 (1991).
Thompson, G. W., Hoover, D. B., Ardell, J. L. & Armour, J. A. Canine intrinsic cardiac neurons involved in cardiac regulation possess NK1, NK2 and NK3 receptors. Am. J. Physiol.-Regul. Integrative Comp. Physiol. 44, 1683–1689 ( 1998).
Moussaoui, S. M. et al. Distribution of neurokinin B in rat spinal cord and peripheral tissues: comparison with neurokinin A and substance P and effects of neonatal capsaican treatment. Neuroscience 48, 969 –978 (1992).
Jansen, I., Alafaci, C., McCulloch, J., Uddman, R. & Edvinsson, L. Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ. J. Cereb. Blood Flow Metab. 11, 567–575 ( 1991).
Baumann, H. & Huch, R. Maternal hemodynamics in pregnancy. Am. J. Obstet. Gynecol. 165, 237– 238 (1991).
Lim, K. H. et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am. J. Pathol. 151, 1809 –1818 (1997).
Lyall, F. & Greer, I. A. The vascular endothelium in normal pregnancy and pre-eclampsia. Rev. Reprod. 1, 107–116 (1996).
Hayman, R., Brockelsby, J., Kenny, L. & Baker, P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J. Soc. Gynecol. Investig. 6, 3–10 (1999).
Campbell, A. et al. Plasma corticotrophin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 64, 1054–1059 (1987).
Page, N. M., Manyonda, I., Butlin, D. J., Bicknell, A. B. & Lowry, P. J. Identification of novel differentially expressed secretory proteins from the human placenta. J. Endocr. 156 (Suppl.), P257 (1998).
Boguski, M. S., Lowe, T. M. & Tolstoshev, C. M. dbEST—database for “expressed sequence tags”. Nature Genet. 4, 332– 333 (1993).
Adams, M. D. et al. Initial assessment of human gene diversity and expression patterns based upon 83-million nucleotides of cDNA sequence. Nature 377, Genome Directory 3S (1995).
Couture, R., Laneuville, O., Guimond, C., Drapeau, G. & Regoli, D. Characterization of the peripheral actions of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn Schmied. Arch. Pharmacol. 340, 547–557 (1989).
Cellier, E., Barbot, L., Regoli, D. & Couture, R. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat. Br. J. Pharmacol. 122, 643–654 ( 1997).
Roccon, A., Marchionni, D. & Nisato, D. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig. Brit. J. Pharmacol. 118, 1095–1102 (1996).
Conrad, K. P., Kerchner, L. J. & Mosher, M. D. Plasma and 24h NOx and cGMP during normal pregnancy and preeclampsia in women on a reduced NOx diet. Am. J. Physiol. 46, F48–F57 ( 1999).
Gecse, A., Kis, B., Mezei, Z. & Telegdy, G. The effect of bradykinin and substance P on the arachidonate cascade of platelets. Immunopharmacology 33, 167–170 (1996).
Perianin, A., Snyderman, R. & Malfroy, B. Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation. Biochem. Biophys. Res. Commun. 161, 520–524 (1989)
Perretti, M., Ahluwalia, A., Flower, R J. & Manzini, S. Endogenous tachykinins play a role in IL-1-induced neutrophil accumulation: involvement of NK-1 receptors. Immunology 80, 73–77 (1993).
Kobari, M. et al. Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats. Eur. J. Pharmacol. 317, 269–274 ( 1996).
Shimizu, T. et al. Occurrence and distribution of substance P receptors in the cerebral blood vessels of the rat. Brain Res. 830, 372–378 (1999).
Stables, J. M. et al. GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptors. Neuropeptides 27, 333–341 (1994).
Baigent, S. M. & Lowry, P. J. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide. J. Mol. Endocrinol. 24, 53–63 (2000).
Clement-Jones, V., Lowry, P. J., Rees, L. H. & Besser, G. M. Met-enkephalin circulates in human plasma. Nature 283 , 295–297 (1980).
Acknowledgements
This work was supported by the Medical Research Council.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Page, N., Woods, R., Gardiner, S. et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature 405, 797–800 (2000). https://doi.org/10.1038/35015579
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/35015579
This article is cited by
-
Role of Neurokinin B in gametogenesis and steroidogenesis of freshwater catfish, Clarias batrachus
Cell and Tissue Research (2023)
-
Female Infertility Is Associated with an Altered Expression Profile of Different Members of the Tachykinin Family in Human Granulosa Cells
Reproductive Sciences (2023)
-
Assessment of Relationship of Serum Neurokinin-B Level in the Pathophysiology of Pre-eclampsia: A Case–Control Study
Advances in Therapy (2018)
-
Association of Inflammatory Cytokines, Lipid Peroxidation End Products and Nitric Oxide with the Clinical Severity and Fetal Outcome in Preeclampsia in Indian Women
Indian Journal of Clinical Biochemistry (2014)
-
Neurokinin B and pre-eclampsia: a decade of discovery
Reproductive Biology and Endocrinology (2010)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.